IFNγ may more effectively induce 5-LO/ALOX5 in AD patient cells because these cells have been primed by chronic inflammation, increasing promoter or enhancer accessibility for IFNγ-driven transcription factors. The gene discussed is IFNG; the disease is Alzheimer disease.